Interleukin-1ß protects against multi-organ endothelial injury

Medicine and Dentistry

1. Adult 5%
2. Adverse Event 5%
3. Aging 7%
4. Amaurosis 5%
5. Angiogenesis 7%
6. Angiotensin 7%
7. Antibody 46%
8. Aorta 5%
9. Apelin 92%
10. Apelin Receptor 29%
11. Aqueous 7%
12. Arterial Stiffness 49%
13. Association 46%
14. Biological Marker 9%
15. Biological Product 11%
16. Brain 5%
17. Brain Areas 5%
18. C57BL/6 5%
19. Cardiac Dysrhythmia 7%
20. Cardiovascular Disease 64%
21. Cardiovascular Risk 53%
22. Cardiovascular System 60%
23. Case-Control Study 10%
24. Cause of Death 14%
25. Cells 5%
26. Chronic Kidney Disease 100%
27. Clearance 5%
28. Complication 14%
29. Corticosterone 5%
30. COVID-19 46%
31. Culture 5%
32. Cytoplasm 5%
33. Death 12%
34. Deterioration 46%
35. Diagnosis 5%
36. Disease 7%
37. Disease Activity 11%
38. Diuresis 7%
39. Drive 11%
40. Endothelial Dysfunction 46%
41. Endothelial Function 8%
42. Endothelin 15%
43. Endothelin 1 18%
44. Endothelin A Receptor 5%
45. Endothelin Receptor 5%
46. Endothelium 17%
47. Enzyme 5%
48. Excretion 5%
49. Fibrinolysis 46%
50. Forearm 5%
51. Gene Linkage 46%
52. Giant-Cell Arteritis 11%
53. Glomerular Filtration Rate 6%
54. Glucocorticoid 46%
55. Hazard Ratio 6%
56. Health 10%
57. Health Care Provider 5%
58. High Salt Diet 5%
59. Hippocampus 5%
60. Human 5%
61. Hydroxysteroid Dehydrogenase 5%
62. Hypertension 5%
63. Hypotension 13%
64. Hypothalamic-Pituitary-Adrenal Axis 46%
65. Hypothalamus 5%
66. Imaging Technique 5%
67. Immune System 5%
68. In Vitro 5%
69. Incidence 7%
70. Inflammatory Disorder 5%
71. Inpatient 49%
72. Kidney 65%
73. Kidney Function 46%
74. Laboratory 5%
75. Ligand 10%
76. Liver 11%
77. Male 5%
78. Measurement 5%
79. Mediator 5%
80. Messenger RNA 28%
81. Monitoring 5%
82. Monocyte 15%
83. Morbidity 19%
84. Mortality 5%
85. Nephropathy 10%
86. Neutrophil 5%
87. Obesity 7%
88. Pathophysiology 5%
89. Patient 87%
90. Patient Referral 5%
91. Pituitary 5%
92. Placebo 10%
93. Plasma 36%
94. Platelet 10%
95. Plethysmography 5%
96. Prevalence 7%
97. Prognostication 5%
98. Public Health 46%
99. Pulse Wave Velocity 23%
100. Receptor Blocking 5%
101. Relapse 5%
102. Renal Diabetes 7%
103. Renin 7%
104. Risk Reduction 5%
105. Salt Intake 92%
106. Serositis 9%
107. Severe Acute Respiratory Syndrome Coronavirus 2 6%
108. Sodium Chloride 28%
109. Sodium Excretion 5%
110. Spontaneous Remission 10%
111. Stress 46%
112. Symptom 5%
113. Tenidap 5%
114. Therapeutic Procedure 80%
115. Thrombocyte Activation 5%
116. Thrombosis 7%
117. Tissue Plasminogen Activator 5%
118. Tissues 56%
119. Toddlers 13%
120. Transcortin 5%
121. Urinary System 5%
122. Vascularity 5%
123. Vasculitis 92%
124. Vasodilatation 17%
125. Vasopressin 19%
126. Volunteer 10%
127. Water 5%
128. Water-Electrolyte Imbalance 7%
129. Woman 9%